- Home
- DARE vs IBIO Comparison
DARE vs IBIO Comparison
Compare DARE & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- IBIO
- Stock Information
- Founded
- DARE N/A
- IBIO 2008
- Country
- DARE United States
- IBIO United States
- Employees
- DARE N/A
- IBIO N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- DARE Health Care
- IBIO Health Care
- Exchange
- DARE Nasdaq
- IBIO Nasdaq
- Market Cap
- DARE 27.9M
- IBIO 24.3M
- IPO Year
- DARE N/A
- IBIO N/A
- Fundamental
- Price
- DARE $3.17
- IBIO $3.48
- Analyst Decision
- DARE Strong Buy
- IBIO Strong Buy
- Analyst Count
- DARE 4
- IBIO 3
- Target Price
- DARE $20.33
- IBIO $4.87
- AVG Volume (30 Days)
- DARE 25.7K
- IBIO 299.1K
- Earning Date
- DARE 03-27-2025
- IBIO 02-10-2025
- Dividend Yield
- DARE N/A
- IBIO N/A
- EPS Growth
- DARE N/A
- IBIO N/A
- EPS
- DARE N/A
- IBIO N/A
- Revenue
- DARE $1,881,316.00
- IBIO $375,000.00
- Revenue This Year
- DARE N/A
- IBIO $36.00
- Revenue Next Year
- DARE $136.52
- IBIO $33.33
- P/E Ratio
- DARE N/A
- IBIO N/A
- Revenue Growth
- DARE 88.13
- IBIO 650.00
- 52 Week Low
- DARE $2.67
- IBIO $1.05
- 52 Week High
- DARE $7.56
- IBIO $4.98
- Technical
- Relative Strength Index (RSI)
- DARE 50.64
- IBIO 55.25
- Support Level
- DARE $2.95
- IBIO $3.22
- Resistance Level
- DARE $3.31
- IBIO $3.76
- Average True Range (ATR)
- DARE 0.15
- IBIO 0.38
- MACD
- DARE 0.01
- IBIO 0.00
- Stochastic Oscillator
- DARE 61.11
- IBIO 56.41
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.